NeuroSense Therapeutics Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NeuroSense Therapeutics Ltd. generated cash of -$8,452,000, which is less than the previous year. Cash used in financing activities reached the amount of $3,895,000 last year. Net change in cash is therefore -$903,000.
Cash Flow
| 2019 | -582K | -26K | 1.41M |
|---|---|---|---|
| 2020 | -695K | -9K | 508K |
| 2021 | -1.53M | -17K | 11.90M |
| 2022 | -7.58M | -3.54M | 3.69M |
| 2023 | -8.45M | 3.46M | 3.89M |
NRSN Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 3.54M | 11.06M | 699K | 895K | 86K |
Operating activities | |||||
Net income | -11.28M | -12.34M | -4.04M | -2.82M | -1.22M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 97K | 89K | 3K | 3K | 0 |
Stock-based compensation expense | 1.53M | 5.10M | 4.15M | 2.06M | 611K |
| Deferred income tax benefit | 1.53M | 5.10M | 4.15M | 2.06M | 611K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 19K | 55K | -204K | -12K | -3K |
Inventories | 0 | -55K | 204K | 12K | 3K |
Accounts payable | 961K | 459K | -16K | 32K | 23K |
Cash generated by operating activities | -8.45M | -7.58M | -1.53M | -695K | -582K |
Investing activities | |||||
Purchases Of Investments | 0 | -3.5M | 0 | 0 | -19K |
Investments In Property Plant And Equipment | -29K | -70K | -17K | -9K | -7K |
Acquisitions Net | 3K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 3.46M | -3.54M | -17K | -9K | -26K |
Financing activities | |||||
Common Stock Issued | 3.97M | 3.87M | 9.86M | 508K | 1.42M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.23M | 0 | 0 |
Cash used in financing activities | 3.89M | 3.69M | 11.90M | 508K | 1.41M |
Net Change In Cash | -903K | -7.52M | 10.36M | -196K | 809K |
Cash at end of period | 2.64M | 3.54M | 11.06M | 699K | 895K |
| Data source | Data source | Data source |